Mobidiag, Autobio plan 30-minute coronavirus test

By staff writers

February 10, 2020 -- Mobidiag of Finland and Autobio Diagnostics of China are developing a rapid test for the novel coronavirus (2019-nCoV) and influenza viruses that they say will enable detection in 30 minutes and will be usable in areas that are hard to reach and lacking trained personnel.

The assay is being developed through Automobi Molecular Diagnostics, a joint venture launched last year. It will deploy Mobidiag's Novodiag real-time polymerase chain reaction (PCR) platform, which allows for screening of single or multiple pathogens.

According to the companies, the test will provide fully automated molecular profiling in a fast and easy-to-use format suitable for triaging high-risk patients in the field. As of February 10 at 16:00 Central European Time, a total of 40,490 cases of 2019-nCoV had been confirmed globally in 25 countries, according to the World Health Organization.

In the U.S., 12 cases have been reported and qualified labs may now use a diagnostic developed by the Centers for Disease Control and Prevention (CDC). The California Department of Public Health announced that 16 labs in the state will be performing testing; the health department lab will start testing on February 12, and it expects to report results within two days of specimen receipt, compared with two to seven days through the CDC.

CMS offers guidance on use of CDC coronavirus test
The U.S. Centers for Medicare and Medicaid Services (CMS) on February 6 offered guidance to medical labs in the field on how to use a diagnostic test...
Wuhan coronavirus RT-PCR tests deliver results fast
Scientists in Hong Kong and China have developed rapid reverse transcription polymerase chain reaction (RT-PCR) tests that may be used to identify and...
FDA shares CDC test with labs on emergency use basis
In a breakthrough for diagnostics amid the Wuhan coronavirus crisis, the U.S. Food and Drug Administration (FDA) has issued an emergency use authorization...
Laboratories, IVD vendors get to work on novel coronavirus
The emergence of novel viruses underscores the need for laboratories to be vigilant and for IVD vendors to constantly update test menus, writes Bruce...

Copyright © 2020

Last Updated np 2/10/2020 12:37:11 PM